Role of neutrophils, MyD88-mediated neutrophil recruitment, and complement in antibody-mediated defense against Pseudomonas aeruginosa keratitis

Investigative Ophthalmology and Visual Science

Volumn 51, Issue 4, 2010, Pages 2085-2093

  Zaidi, Tanweer S ^a   Zaidi, Tauqeer ^a   Pier, Gerald B ^a  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

COBROTOXIN; COMPLEMENT COMPONENT C3; MONOCLONAL ANTIBODY; MONOCLONAL ANTIBODY F429; MYELOID DIFFERENTIATION FACTOR 88; UNCLASSIFIED DRUG; ALGK PROTEIN, PSEUDOMONAS AERUGINOSA; BACTERIAL PROTEIN; BACTERIUM ANTIBODY; IMMUNOGLOBULIN G; MYD88 PROTEIN, MOUSE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIBACTERIAL ACTIVITY; ARTICLE; BACTERIAL STRAIN; BACTERIUM ISOLATE; COMPLEMENT SYSTEM; CONTROLLED STUDY; DRUG ADMINISTRATION ROUTE; DRUG EFFICACY; DRUG RESPONSE; KERATITIS; KNOCKOUT MOUSE; MOUSE; NEUTROPENIA; NEUTROPHIL CHEMOTAXIS; NONHUMAN; PRIORITY JOURNAL; PROTEIN DETERMINATION; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; PSEUDOMONAS AERUGINOSA; PSEUDOMONAS INFECTION; ANIMAL; BACTERIAL EYE INFECTION; BAGG ALBINO MOUSE; C3H MOUSE; C57BL MOUSE; CORNEA ULCER; GENE SILENCING; GENETICS; IMMUNOLOGY; MOUSE MUTANT; NEUTROPHIL; PHYSIOLOGY;

ANIMALS; ANTIBODIES, BACTERIAL; ANTIBODIES, MONOCLONAL; BACTERIAL PROTEINS; COMPLEMENT C3; CORNEAL ULCER; EYE INFECTIONS, BACTERIAL; GENE SILENCING; IMMUNOGLOBULIN G; MICE; MICE, INBRED BALB C; MICE, INBRED C3H; MICE, INBRED C57BL; MICE, KNOCKOUT; MYELOID DIFFERENTIATION FACTOR 88; NEUTROPHIL INFILTRATION; NEUTROPHILS; PSEUDOMONAS INFECTIONS;

EID: 77951241716     PISSN: 01460404     EISSN: 15525783     Source Type: Journal    
DOI: 10.1167/iovs.09-4139     Document Type: Article

References (34)

1. Hazlett LD. Bacterial infections of the cornea (Pseudomonas aeruginosa). Chem Immunol Allergy. 2007;92:185-194.
2. Robertson DM, Petroll WM, Jester JV, Cavanagh HD. Current concepts: contact lens related Pseudomonas keratitis. Cont Lens Anterior Eye. 2007;30:94-107.
3. Thomas PA, Geraldine P. Infectious keratitis. Curr Opin Infect Dis. 2007;20:129-141.
4. Willcox MD. Pseudomonas aeruginosa infection and inflammation during contact lens wear: a review. Optom Vis Sci. 2007;84: 273-278.
5. Stapleton F, Keay L, Jalbert I, Cole N. The epidemiology of contact lens-related infiltrates. Optom Vis Sci. 2007;84:257-272.
6. Fleiszig SM. The Glenn A. Fry award lecture 2005. The pathogenesis of contact lens-related keratitis. Optom Vis Sci. 2006;83:866-873.
7. Vajpayee RB, Sharma N, Sinha R, Agarwal T, Singhvi A. Infectious keratitis following keratoplasty. Surv Ophthalmol. 2007;52:1-12.
8. Wroblewski KJ, Pasternak JF, Bower KS, et al. Infectious keratitis after photorefractive keratectomy in the United States Army and Navy. Ophthalmology. 2006;113:520-525.
9. Swarbrick HA. Orthokeratology review and update. Clin Exp Optom. 2006;89:124-143.
10. Panda A, Satpathy G, Nayak N, Kumar S, Kumar A. Demographic pattern, predisposing factors and management of ulcerative keratitis: evaluation of one thousand unilateral cases at a tertiary care centre. Clin Experiment Ophthalmol. 2007;35:44-50.
11. Zaidi T, Pier GB. Prophylactic and therapeutic efficacy of a fully human immunoglobulin G1 monoclonal antibody to Pseudomonas aeruginosa alginate in murine keratitis infection. Infect Immun. 2008;76:4720-4725.
12. Pier GB, Thomas D, Small G, Siadak A, Zweerink H. In vitro and in vivo activity of polyclonal and monoclonal human immunoglobulin G, M and A against Pseudomonas aeruginosa lipopolysaccharide. Infect Immun. 1989;57:174-179.
13. Kumar A, Hazlett LD, Yu FS. Flagellin suppresses the inflammatory response and enhances bacterial clearance in a murine model of Pseudomonas aeruginosa keratitis. Infect Immun. 2008;76:89-96.
14. Szliter EA, Barrett RP, Gabriel MM, Zhang Y, Hazlett LD. Pseudomonas aeruginosa-induced inflammation in the rat extendedwear contact lens model. Eye Contact Lens. 2006;32:12-18.
15. Hazlett LD. Role of innate and adaptive immunity in the pathogenesis of keratitis. Ocul Immunol Inflamm. 2005;13:133-138.
16. Chusid MJ, Nelson DB, Meyer LA. The role of the polymorphonuclear leukocyte in the induction of corneal edema. Invest Ophthalmol Vis Sci. 1986;27:1466-1469.
17. Thakur A, Xue M, Stapleton F, Lloyd AR, Wakefield D, Willcox MD. Balance of pro- and anti-inflammatory cytokines correlates with outcome of acute experimental Pseudomonas aeruginosa keratitis. Infect Immun. 2002;70:2187-2197.
18. Preston MJ, Fleiszig SMJ, Zaidi TS, et al. Rapid and sensitive method for evaluating Pseudomonas aeruginosa virulence factors during corneal infections in mice. Infect Immun. 1995;63:3497-3501.
19. Fleiszig SMJ, Wiener-Kronish JP, Miyazaki H, et al. Pseudomonas aeruginosa-mediated cytotoxicity and invasion correlate with distinct genotypes at the loci encoding exoenzyme S. Infect Immun. 1997;65:579-586.
20. Pier GB, Boyer D, Preston M, et al. Human monoclonal antibodies to Pseudomonas aeruginosa alginate that protect against infection by both mucoid and nonmucoid strains. J Immunol. 2004; 173:5671-5678.
21. Koh AY, Kohler JR, Coggshall KT, Van Rooijen N, Pier GB. Mucosal damage and neutropenia are required for Candida albicans dissemination. PLoS Pathog. 2008;4:e35.
22. Fitzgerald KA, Chen ZJ. Sorting out Toll signals. Cell. 2006;125: 834-836.
23. Power MR, Peng Y, Maydanski E, Marshall JS, Lin TJ. The development of early host response to Pseudomonas aeruginosa lung infection is critically dependent on myeloid differentiation factor 88 in mice. J Biol Chem. 2004;279:49315-49322.
24. Cleveland RP, Hazlett LD, Leon MA, Berk RS. Role of complement in murine corneal infection caused by Pseudomonas aeruginosa. Invest Ophthalmol Vis Sci. 1983;24:237-242.
25. Koh AY, Priebe GP, Pier GB. Virulence of Pseudomonas aeruginosa in a murine model of gastrointestinal colonization and dissemination in neutropenia. Infect Immun. 2005;73:2262-2272.
26. Chusid MJ, Davis SD. Experimental bacterial keratitis in neutropenic guinea pigs: polymorphonuclear leukocytes in corneal host defense. Infect Immun. 1979;24:948-952.
27. Hazlett LD, Rosen DD, Berk RS. Pseudomonas eye infections in cyclophosphamide-treated mice. Invest Ophthalmol Vis Sci. 1977; 16:649-652.
28. Zheng M, Fields MA, Liu Y, Cathcart HM, Richter E, Atherton SS. Neutrophils protect the retina of the injected eye from infection after anterior chamber inoculation of HSV-1 in BALB/c mice. Invest Ophthalmol Vis Sci. 2008;49:4018-4025.
29. Shah SS, Gallagher PG. Complications of conjunctivitis caused by Pseudomonas aeruginosa in a newborn intensive care unit. Pediatr Infect Dis J. 1998;17:97-102.
30. Shah SS, Gloor P, Gallagher PG. Bacteremia, meningitis, and brain abscesses in a hospitalized infant: complications of Pseudomonas aeruginosa conjunctivitis. J Perinatol. 1999;19:462-465.
31. O'Keefe M, Nolan L, Lanigan B, Murphy J. Pseudomonas aeruginosa endophthalmitis in a preterm infant. J AAPOS. 2005;9:288-289.
32. Markiewski MM, Lambris JD. The role of complement in inflammatory diseases from behind the scenes into the spotlight. Am J Pathol. 2007;171:715-727.
33. Verhagen C, Breebaart AC, Kijlstra A. The effects of complement depletion on corneal inflammation in rats. Invest Ophthalmol Vis Sci. 1992;33:273-279.
34. Hazlett LD, Berk RS. Effect of C3 depletion on experimental Pseudomonas aeruginosa ocular infection: histopathological analysis. Infect Immun. 1984;3:783-790.